Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Understanding ADLs and IADLs

What are ADLs and IADLs? One of the most difficult parts of aging is the inability to complete basic self-care tasks on a day-to-day basis required for independent living. These daily tasks fall into two categories: Activities of Daily Living (ADLs) and Instrumental Activities for Daily Living (IADLs). What are Activities of Daily Living (ADLs)…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Start free

What are ADLs and IADLs?

One of the most difficult parts of aging is the inability to complete basic self-care tasks on a day-to-day basis required for independent living. These daily tasks fall into two categories: Activities of Daily Living (ADLs) and Instrumental Activities for Daily Living (IADLs).

What are Activities of Daily Living (ADLs)

ADLs are the basic self-care tasks that typically develop in early childhood. It’s easy to take ADLs for granted when you are young and healthy, however, due to a variety of health issues and the general effects of aging, many of these everyday tasks start to become more difficult for seniors to complete on their own. The six primary ADLs include:

  • Functional mobility such as the ability to walk or safely get in and out of a bed or a chair
  • Grooming and personal hygiene, including skin and hair care
  • Showering or bathing
  • Toileting, including the ability to safely get on and off the toilet
  • Dressing, which includes selecting appropriate attire and putting it on
  • Self-feeding

Why do ADLs Matter?

It’s important to understand ADLs when determining the proper level of care for a loved one or resident. Some ADLs require less constant care while others, like toileting, require 24/7 care. Considering whether to move a family member to an assisted living facility or a nursing home is a big decision that should be well thought out. Another crucial role ADLs play is in providing a standard that many insurance companies use to determine the level of coverage to provide.The number of ADLs a senior needs help with, will usually determine whether or not they qualify for assistance in paying for an assisted living home, a nursing home, or in-home care. For many long-term care insurance policies, the inability to perform two ADLs or more is the point where the insurance provider will start paying on the policy.

What about Instrumental Activities of Daily Living (IADLs)?

We often hear about ADLs, but Instrumental Activities of Daily Living, or IADLs, is another important category that caregivers should be familiar with. IADLs are tasks that are instrumental to living independently but don’t require the same level of care to complete as ADLs. While they are not a requirement for basic health and survival, they do impact quality of life. The main IADLs to be aware of are:

  • Managing finances
  • Handling transportation
  • Preparing meals
  • Managing medications
  • Housework and basic home maintenance

Older adults living at home need to be able to manage the ADLs and IADLs above in order to live independently. While staying independent is very important, no senior should have to struggle with or be deprived of basic self-care. Knowing the ADLs and IADLs is critical in recognizing when a loved one needs assistance and when a care plan is necessary.

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.
B2B Weekly

The week in Healthcare, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free plan

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale workspace, up to 10 people
One professional video edit a month for qualifying companies
Media requests to your crowd, remote recording, AI writing tools
$0, no credit card, nothing that expires

More Healthcare Insights

NICE recommends Enhertu for HER2-low advanced breast cancer in England

NICE recommends Enhertu for HER2-low advanced breast cancer in England

American Pharmaceutical Review reported that NICE has recommended Enhertu for routine NHS use in people with HER2-low advanced breast cancer, following a commercial agreement and updates to NICE’s methods under the U.K.-U.S. Pharmaceutical Pricing Agreement.

  • 01NICE tied the reversal to 2026 changes: higher cost-effectiveness thresholds that took effect in April and a new quality-of-life assessment method published Aug. 27, 2026.
  • 02Access planning still varies by nation: Fierce Pharma reported Wales requires funding within 60 days of final guidance, while Scotland and Northern Ireland follow separate processes.

Sep 21, 2026

Eli Lilly’s $6.5B Houston Bet Highlights U.S. Pharma Reshoring

Eli Lilly’s $6.5B Houston Bet Highlights U.S. Pharma Reshoring

Eli Lilly has broken ground on a $6.5 billion manufacturing facility in Houston, slated for completion around 2030. While attention has focused on scaling production of Foundayo, its oral GLP-1 treatment, the project also reflects broader U.S. efforts to rebuild domestic pharmaceutical manufacturing and highlights the supply chain challenge of forecasting demand and building capacity years in advance.

  • 01Eli Lilly commits $6.5 billion to a Houston pharmaceutical manufacturing facility due for completion around 2030, one of the largest single U.S. pharma production investments in recent years
  • 02GLP-1 demand forecasting remains highly uncertain: Lilly's CEO noted that one-third of new GLP-1 pill patients are now choosing Foundayo, illustrating fast-moving market share shifts that complicate production planning years in advance
  • 03Houston's selection reflects industrial capacity and workforce depth, positioning the region as a biomanufacturing corridor and creating long-term hiring demand in engineering, quality control, and skilled trades

Sep 21, 2026

Waiting for perfectly clean data is stalling healthcare AI, not protecting it

Healthcare organizations often delay AI initiatives waiting for perfectly clean data, but this assumption no longer holds: reliable subsets and synthetic data allow projects to start now while data work continues in parallel. Success requires starting with business outcomes rather than technology capabilities, and embedding governance in product strategy before implementation, not after.

  • 01Waiting for 100% clean data is effectively a decision never to start; hospital AI projects can begin on reliable data subsets while quality work continues in parallel.
  • 02Frame AI decisions around business outcomes (revenue growth, cost reduction, competitive advantage, new products, or ecosystem influence) rather than asking what AI can do.
  • 03Governance should be part of product strategy before design or purchase, especially as agentic AI takes actions—such as handling many revenue-cycle denials—while routing the rest to humans.

Sep 21, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512